| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.25B | +0.7% |
| Gross Profit | $4.59B | -2.1% |
| R&D Expense | $775.0M | +2.2% |
| SG&A Expense | $2.78B | +24.0% |
| Operating Income | $1.04B | -38.8% |
| Pre-tax Income | $605.0M | -63.7% |
| Income Tax | $127.0M | -60.4% |
| Net Income | $479.0M | -64.4% |
| EPS (Basic) | $2.77 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $762.0M | +292.8% |
| Accounts Receivable | $1.04B | -20.5% |
| Inventory | $965.0M | +12.6% |
| Current Assets | $3.25B | +29.0% |
| Total Assets | $14.46B | +3.7% |
| Current Liabilities | $2.70B | +56.4% |
| Long-term Debt | $8.01B | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.19B | -38.1% |
| Capital Expenditures | $380.0M | +31.0% |
| Investing Cash Flow | -$380.0M | -65.2% |
| Financing Cash Flow | -$240.0M | +84.5% |
| Free Cash Flow | $805.0M | -50.5% |
| -64.4% |
| EPS (Diluted) | $2.76 | -64.6% |
| Total Liabilities |
| $11.50B |
| +405.0% |
| Stockholders' Equity | $2.96B | -74.6% |